JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
BTAI Financials - Bioxcel Therapeutics Income & Cash Flow | Ledgeburg
BTAI - Bioxcel Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary BTAI Stock
Financials
Financials BTAI Stock
Loading...
Loading...
Income Statement
Income Statement BTAI Stock
Balance Sheet
Balance Sheet BTAI Stock
Cash Flow Statement
Cash Flow Statement BTAI Stock
Loading...
Loading...
Home
Stocks
Bioxcel Therapeutics, Inc. (BTAI)
Financials
Financials of BTAI
Loading...
Loading...
Loading...
Loading...
Revenue
$642K
Operating Income
$-50.461M
Net Income
$-69.897M
Share Count (Basic)
12.208M
Operating Cash Flow
$-57.615M
Free Cash Flow
$-57.615M
Cash And Short-Term Equivalents
$28.415M
Total Debt
$109.594M
Annual
Quarterly
Revenue $USD
0
500K
1M
1.5M
2M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50K
100K
150K
200K
250K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-150M
-100M
-50M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-40000%
-30000%
-20000%
-10000%
0%
Q1 FY26
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-25M
-20M
-15M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-30000%
-20000%
-10000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26